56055-54-0

• 

• Basic information

  1. Product Name: METHYL 5,6-DICHLORONICOTINATE
  2. Synonyms: METHYL 5,6-DICHLORONICOTINATE;3-pyridinecarboxylic acid, 5,6-dichloro-, methyl ester;Methyl 5,6-dichloropyridine-3-carboxylate;Methyl 5,6-dichloropyridine-3-carboxylate, 5,6-Dichloro-3-(methoxycarbonyl)pyridine;Methyl 5,6-dichloropyridine-3-carboxylate, 2,3-Dichloro-5-(methoxycarbonyl)pyridine;3W-0272;5,6-dichloro-3-pyridinecarboxylic acid methyl ester;ZINC00168870
  3. CAS NO:56055-54-0
  4. Molecular Formula: C₇H₅Cl₂NO₂
  5. Molecular Weight: 206.03
  6. EINECS: 200-258-5
  7. Product Categories: N/A
  8. Mol File: 56055-54-0.mol

• Chemical Properties

  1. Melting Point: 63-65°C
  2. Boiling Point: 265.5°Cat760mmHg
  3. Flash Point: 114.3°C
  4. Appearance: /
  5. Density: 1.426g/cm³
  6. Vapor Pressure: 0.00915mmHg at 25°C
  7. Refractive Index: 1.548
  8. Storage Temp.: under inert gas (nitrogen or Argon) at 2-8°C
  9. Solubility: N/A
  10. PKA: -2.84±0.10(Predicted)
  11. CAS DataBase Reference: METHYL 5,6-DICHLORONICOTINATE(CAS DataBase Reference)
  12. NIST Chemistry Reference: METHYL 5,6-DICHLORONICOTINATE(56055-54-0)
  13. EPA Substance Registry System: METHYL 5,6-DICHLORONICOTINATE(56055-54-0)

• Safety Data

  1. Hazard Codes: N/A
  2. Statements: 36/37/38
  3. Safety Statements: 26-36/37/39
  4. WGK Germany:
  5. RTECS:
  6. HazardClass: IRRITANT
  7. PackingGroup: N/A
  8. Hazardous Substances Data: 56055-54-0(Hazardous Substances Data)

• Suppliers
• Usage
• SDS
• Upstream product
• Downstream Products
• Article

56055-54-0 Suppliers

Recommended suppliers

• Product
• FOB Price
• Min.Order
• Supply Ability
• Supplier
• Contact Supplier

View More

56055-54-0 Usage

Uses

Used in Chemical Synthesis:
METHYL 5,6-DICHLORONICOTINATE is used as an intermediate compound for the synthesis of more complex organic compounds and chemicals. Its unique structure with a chlorinated pyridine ring allows for further chemical reactions and modifications, making it a valuable component in the development of new chemical entities.
Used in Pharmaceutical Industry:
METHYL 5,6-DICHLORONICOTINATE is used as a building block in the synthesis of pharmaceutical compounds. Its presence in the molecular structure can contribute to the development of new drugs with potential therapeutic applications, such as in the treatment of various diseases and medical conditions.
Used in Agrochemical Industry:
METHYL 5,6-DICHLORONICOTINATE is used as a precursor in the production of agrochemicals, such as pesticides and herbicides. Its chemical properties can be exploited to create effective compounds that can protect crops from pests and weeds, thereby increasing agricultural productivity.
Used in Dye and Pigment Industry:
METHYL 5,6-DICHLORONICOTINATE is used as a starting material in the synthesis of dyes and pigments. Its chemical structure can be modified to produce a wide range of colors, which can be used in various applications, such as textiles, plastics, and paints.
Used in Research and Development:
METHYL 5,6-DICHLORONICOTINATE is used as a research compound in academic and industrial laboratories. Its unique properties and reactivity make it an interesting subject for studies in organic chemistry, materials science, and related fields, potentially leading to new discoveries and applications.

Check Digit Verification of cas no

The CAS Registry Mumber 56055-54-0 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 5,6,0,5 and 5 respectively; the second part has 2 digits, 5 and 4 respectively.
Calculate Digit Verification of CAS Registry Number 56055-54:
(7*5)+(6*6)+(5*0)+(4*5)+(3*5)+(2*5)+(1*4)=120
120 % 10 = 0
So 56055-54-0 is a valid CAS Registry Number.

InChI:InChI=1/C7H5Cl2NO2/c1-12-7(11)4-2-5(8)6(9)10-3-4/h2-3H,1H3

56055-54-0SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 18, 2017

Revision Date: Aug 18, 2017

1.Identification

1.1 GHS Product identifier

Product name	Methyl 5,6-Dichloronicotinate

1.2 Other means of identification

Product number	-
Other names	methyl 5,6-dichloropyridine-3-carboxylate

1.3 Recommended use of the chemical and restrictions on use

Identified uses	For industry use only.
Uses advised against	no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number	-
Service hours	Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:56055-54-0 SDS

56055-54-0Upstream product

• 67-56-1 methanol 
• 54127-29-6 5,6-dichloronicotinoyl chloride 
• 365413-29-2 6-chloro-5-iodonicotinic acid methyl ester 
• 885950-46-9 6-hydroxy-5-iodonicotinic acid methyl ester 
• 66171-50-4 methyl 6-hydroxynicotinate 
• 5006-66-6 6-hydroxy-3-pyridinecarboxylic acid 
• 41667-95-2 5,6-dichloronicotinic acid 
• 18107-18-1 diazomethyl-trimethyl-silane 

56055-54-0Downstream Products

• 51269-81-9 methyl 5-chloropyridine-3-carboxylate 
• 220656-93-9 methyl 5-chloro-6-methoxypyridine-3-carboxylate 
• 106014-21-5 dimethyl 3-chloropyridine-2,5-dicarboxylate 
• 951771-57-6 5-chloro-6-(4-chloro-phenylamino)-nicotinic acid methyl ester 
• 683241-92-1 6-(4-(tert-butoxycarbonyl)piperazin-1-yl)-5-chloronicotinic acid 

56055-54-0Relevant articles and documents

INHIBITORS OF MALT1 AND USES THEREOF

-

Paragraph 00391, (2018/09/28)

Provided herein are compounds that inhibit MALTl, a protein whose activity is responsible for constitutive NF-κΒ signaling in certain cancers (e.g., activated B-cell diffuse large B-cell lymphoma (ABC-DLBCL)). Also provided are pharmaceutical compositions and kits comprising the compounds, and methods of treating MALTl -related diseases and disorders (e.g., cancer) with the compounds in a subject, by administering the compounds and/or compositions described herein.

Novel compounds

-

Paragraph 0063, (2017/09/27)

The present invention relates to novel retinoid-related orphan receptor gamma (RORγ) modulators and their use in the treatment of diseases mediated by RORγ.

NOVEL COMPOUNDS

-

Page/Page column 22, (2015/12/17)

The preseent invention relates to novel retinoid-related orphan receptor gamma(RORγ)modulators and their use in the treatment ofdiseases mediated by RORγ.

NOVEL COMPOUNDS

-

Page/Page column 14, (2015/12/18)

The present invention relates to novel retinoid-related orphan receptor gamma (RORγ) modulators and their use in the treatment of diseases mediated by RORγ.

NOVEL COMPOUNDS

-

Page/Page column 76; 77, (2015/12/17)

Disclosed are novel retinoid-related orphan receptor gamma (RORγ) modulators and their use in the treatment of diseases mediated by RORγ.

NOVEL COMPOUNDS FOR MODULATION OF ROR-GAMMA ACTIVITY

-

Paragraph 00313, (2014/03/22)

The present invention relates to aryl sulfones and related compounds that are modulators of ROR-gamma receptors. The invention also provides pharmaceutical compositions comprising these modulators, and methods of modulating ROR-gamma receptors using them. Also provided are methods of using aryl sulfones and related compounds as modulators of ROR-gamma to treat ROR-gamma mediated diseases

Development of a safe and economical synthesis of methyl 6-chloro-5-(trifluoromethyl)nicotinate: Trifluoromethylation on kilogram scale

Mulder, Jason A.,Frutos, Rogelio P.,Patel, Nitinchandra D.,Qu, Bo,Sun, Xiufeng,Tampone, Thomas G.,Gao, Joe,Sarvestani, Max,Eriksson, Magnus C.,Haddad, Nizar,Shen, Sherry,Song, Jinhua J.,Senanayake, Chris H.

supporting information, p. 940 - 945 (2013/07/26)

Reported herein is a safe and economical synthesis of methyl 6-chloro-5-(trifluoromethyl)nicotinate, an intermediate in the synthesis of novel anti-infective agents. The key to this process is the trifluoromethylation of an aryl iodide using an inexpensive methyl chlorodifluoroacetate (MCDFA)/KF/CuI system, with an emphasis on the development work which led to this effective process.

Novel Biaryl Benzolmidazole Derivatives and Pharmaceutical Composition Comprising The Same

-

Page/Page column 15; 7, (2009/09/05)

Disclosed are biaryl benzoimidazole derivatives. They have an inhibitory effect on calcium influx in HEK cells, thereby showing a powerful antagonistic effect on a vanilloid receptor, and further have an analgesic effect, thereby being useful for preventi

Organic compounds

-

Page/Page column 22, (2009/05/29)

The present invention relates to novel benzimidazole derivatives, their preparation, their use as pharmaceuticals and pharmaceutical compositions containing them, wherein the compounds have the formula (I): in which the substitutents are as defined in claim 1 and salts, solvates, hydrates and N-oxides thereof.

NOVEL BIARYL BENZOIMIDAZOLE DERIVATIVES AND PHARMACEUTICAL COMPOSITION COMPRISING THE SAME

-

Page/Page column 15; 26, (2008/06/13)

The biaryl benzoimidazole derivative of the present invention has an excellent inhibitory effect on calcium influx in HEK cells, thereby showing a powerful antagonistic effect on a vanilloid receptor, and further has an excellent analgesic effect, thereby

Post a RFQ

Cas No.:

Product Name:

Quantity:

Please select Metric Ton KG G Pound L ML

Email:

Company name:

Valid Period:

Detailed Requirements:

• Sample
• MOQ
• GMP
• FDA
• Price
  FOB CIF CFR EXW
• Urgent purchase

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

Remove

Submit

1

What can I do for you?
Get Best Price

Get Best Price for 56055-54-0 METHYL 5,6-DICHLORONICOTINATE

Send

Send

Metric Ton KG G Pound L ML

Send

Send